VCIM
CGEM icon

Velan Capital Investment Management’s Cullinan Oncology CGEM Stock Holding History

Velan Capital Investment Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-75,000
Closed -$679K – 23
2023
Q3 		$679K Buy
75,000
+25,000
+50% +$260K 0.55% 24
2023
Q2 		$538K Buy
+50,000
New +$531K 0.5% 30

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Velan Capital Investment Management's CGEM Position: Q4 2023 in Review

Velan Capital Investment Management sold out of Cullinan Oncology (CGEM) in Q4 2023, closing a stake of 75,000 shares — an estimated $679K sold.

Velan Capital Investment Management first reported a position in CGEM in Q2 2023 and held it in 2 quarters. The position peaked at $679K in Q3 2023. 113 funds tracked by Wall St. Rank hold CGEM as of Q4 2023.

  • Velan Capital Investment Management reported no remaining Cullinan Oncology position as of Q4 2023 after selling out during the quarter.
  • Velan Capital Investment Management sold 75,000 Cullinan Oncology shares in Q4 2023, an estimated $679K.
  • Velan Capital Investment Management first reported a position in Cullinan Oncology in Q2 2023 and held it in 2 quarters.
  • Velan Capital Investment Management's Cullinan Oncology position peaked at $679K in Q3 2023.
  • 113 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2023.

Based on Velan Capital Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.